BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15784141)

  • 1. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
    Ghoussaini M; Meyre D; Lobbens S; Charpentier G; Clément K; Charles MA; Tauber M; Weill J; Froguel P
    BMC Med Genet; 2005 Mar; 6():11. PubMed ID: 15784141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR-gamma2 pro12Ala polymorphism is associated with post-challenge abnormalities of glucose homeostasis in children and adolescents with obesity.
    Jermendy A; Körner A; Kovács M; Madácsy L; Cseh K
    J Pediatr Endocrinol Metab; 2011; 24(1-2):55-9. PubMed ID: 21528816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects.
    Mirzaei H; Akrami SM; Golmohammadi T; Doosti M; Heshmat R; Nakhjavani M; Amiri P
    Metab Syndr Relat Disord; 2009 Oct; 7(5):453-8. PubMed ID: 19558269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between the Pro12Ala polymorphism of the PPAR-gamma 2 gene and type 2 diabetes mellitus in the Qatari consanguineous population.
    Badii R; Bener A; Zirie M; Al-Rikabi A; Simsek M; Al-Hamaq AO; Ghoussaini M; Froguel P; Wareham NJ
    Acta Diabetol; 2008 Mar; 45(1):15-21. PubMed ID: 17805473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.
    Danawati CW; Nagata M; Moriyama H; Hara K; Yasuda H; Nakayama M; Kotani R; Yamada K; Sakata M; Kurohara M; Wiyono P; Asdie H; Sakaue M; Taniguchi H; Yokono K
    Diabetes Metab Res Rev; 2005; 21(5):465-9. PubMed ID: 15739197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.
    Buzzetti R; Petrone A; Caiazzo AM; Alemanno I; Zavarella S; Capizzi M; Mein CA; Osborn JA; Vania A; di Mario U
    Pediatr Res; 2005 Jan; 57(1):138-40. PubMed ID: 15531738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
    Swarbrick MM; Chapman CM; McQuillan BM; Hung J; Thompson PL; Beilby JP
    Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR-gamma2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity.
    Scaglioni S; Verduci E; Salvioni M; Biondi ML; Radaelli G; Agostoni C; Giovannini M
    Pediatr Res; 2006 Oct; 60(4):485-9. PubMed ID: 16940242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects.
    Li LL; Ma XL; Ran JX; Sun XF; Xu LM; Ren J; Mao XM
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):187-91. PubMed ID: 17941898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome.
    Dongxia L; Qi H; Lisong L; Jincheng G
    Circ J; 2008 Apr; 72(4):551-7. PubMed ID: 18362424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population.
    Ben Ali S; Ben Yahia F; Sediri Y; Kallel A; Ftouhi B; Feki M; Elasmi M; Haj-Taieb S; Souheil O; Sanhagi H; Slimane H; Jemaa R; Kaabachi N
    Clin Biochem; 2009 Nov; 42(16-17):1642-7. PubMed ID: 19733160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
    Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
    Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between the Pro12Ala variant in the PPARγ2 gene and type 2 diabetes mellitus and obesity in a Chinese population.
    Wang X; Liu J; Ouyang Y; Fang M; Gao H; Liu L
    PLoS One; 2013; 8(8):e71985. PubMed ID: 23991018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of the Pro12Ala and C1431T polymorphism of the PPAR gamma2 gene and their haplotypes with obesity and type 2 diabetes].
    Dong CP; He L; Li JN; Ye F; He M; Wang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):447-51. PubMed ID: 18683148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.
    Radha V; Vimaleswaran KS; Babu HN; Abate N; Chandalia M; Satija P; Grundy SM; Ghosh S; Majumder PP; Deepa R; Rao SM; Mohan V
    Diabetes Care; 2006 May; 29(5):1046-51. PubMed ID: 16644635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population.
    Robiou-du-Pont S; Bonnefond A; Yengo L; Vaillant E; Lobbens S; Durand E; Weill J; Lantieri O; Balkau B; Charpentier G; Marre M; Froguel P; Meyre D
    Int J Obes (Lond); 2013 Jul; 37(7):980-5. PubMed ID: 23090577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.
    Meirhaeghe A; Fajas L; Helbecque N; Cottel D; Auwerx J; Deeb SS; Amouyel P
    Int J Obes Relat Metab Disord; 2000 Feb; 24(2):195-9. PubMed ID: 10702770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.
    Li S; Chen W; Srinivasan SR; Boerwinkle E; Berenson GS;
    Diabetes; 2003 May; 52(5):1265-9. PubMed ID: 12716762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.